Frontlight ResearchEarly access
Trial site
Samsun
- 10running trials
- 7closed trials
The trials here
What the 17 trials at this site are about, from their registry records.
- Conditions
- Multiple sclerosis5 trials
- Chronic myeloid leukaemia3 trials
- Chronic spontaneous urticaria3 trials
- Coronary artery disease2 trials
- Immune thrombocytopenia (ITP)2 trials
- Myelodysplastic syndromes2 trials
- Myeloproliferative neoplasms2 trials
- Stroke2 trials
- Acute lymphoblastic leukaemia1 trial
- Childhood cancers1 trial
- Phase
- Phase 315 trials
- Phase 21 trial
- Phase 41 trial
- Status
- Active, not recruiting8 trials
- Completed5 trials
- Recruiting2 trials
- Terminated2 trials
- Lead sponsor
- Novartis Pharmaceuticals17 trials
Running trials
Recruiting
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Active, not recruiting
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Myeloproliferative neoplasms2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- Childhood cancers1 recruiting
- Chronic myeloid leukaemia1 recruiting
Closed trials
Completed
Completed
Completed
Terminated
Completed
Terminated
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026